Delivering >90% compliance in real-world studies

Book a demo today and see how uMotif’s eCOA/ePRO platform drives unparalleled levels of patient engagement to transform the speed, quality and accuracy of data.

uMotif’s eCOA/ePRO platform is designed for patients first. It powers unrivaled patient engagement and is trusted by leading pharma & biotech organizations across the globe.

uMotif’s next generation eCOA/ePRO platform covers all aspects of clinical, post-marketing and real-world research.

Our deep understanding of how to engage patients to help them overcome the burden of trail participation is proven to achieve >90% eCOA/ePRO compliance and reduce study timelines by up to 30%.

Our patient-first approach has powered all study sizes, from large-scale virtual studies with over 13,000 participants, all the way down to pediatric rare disease studies with just 60 critical families.

eCOA/ePRO Insights

Insights from our patient engagement experts

High Compliance Icon

High Compliance

Over 90% compliance in real-world studies

Faster Studies icon

Faster Studies

Reducing study timelines by ⅓

Quality Data icon

Quality Data

Capturing GCP-compliant data, ready for submission


Get in touch with us

We may process your personal information for carefully considered and specific purposes which are in our legitimate business interests and enable us to enhance the services we provide, but which we believe also benefit you. Click here to learn more about what we mean by legitimate interests, and when we may process your information in this way.

“We needed an easy-to-use solution, that can be used across multiple countries, to manage a high volume of data capture – uMotif’s platform provides the opportunity to engage our patients”

Professor Pratik Choudhary Project Lead, King’s College London

Trusted by leading companies

across the globe: